Synergy Pharma Cash Flow - Quarterly (NASDAQ:SGYP)

Add to My Stocks
$1.69 $0.01 (0.6%) SGYP stock closing price Sep 18, 2018 (Closing)

The Synergy Pharma cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Synergy Pharma profits one has to check the income statement and for Synergy Pharma debt one has to check the balance sheet. This statement can tell if a company is running out of money while still being profitable and is useful in Synergy Pharma stock analysis. Synergy Pharma had a negative net income cash flow of $-65.8M till this quarter of 2018 Q2. This report is very useful in measuring the short term viability of a company. SGYP decrease in investments stood at a value of $-0.19M for the latest quarter 2018 Q2.

View and download details of Synergy Pharma cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
-65.8M-36.1M-224.33M-187.36M-138.49M-64.6M-198.6M-138.74M-98.49M-59.94M
Depreciation Depletion Amortization Cash-Flow--1.5M1.13M--7.15M4.85M4.48M4.19M
Net Increase (Decrease) in Assets Liabilities-10.27M--13M-15.72M-0.38M-3.48M6.62M5.49M2.58M-0.36M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net1.66M-0.09M22.94M21.9M17.24M3.98M55.07M36.4M31.29M28.56M
Net Cash from (used by) Operating Activities
-73.49M-35.75M-212.88M-180.05M-120.77M-63.45M-129.75M-91.98M-60.12M-27.55M
Increase (Decrease) in Prop Plant And Equipment-0.19M-0.1M-0.21M-0.04M-0.01M-0.01M-0.29M-0.29M-0.27M-0.04M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments------50.09M50.09M50.09M50.09M
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
-0.19M-0.1M-0.21M-0.04M-0.01M-0.01M49.8M49.8M49.82M50.05M
Issuance (Purchase) of Equity Shares--174.14M122.29M122.29M122.28M101.39M90.05M89.86M-
Issuance (Repayment) of Debt Securities--95.14M95.14M------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-2.5M-2.5M-1.59M-1.93M-1.93M-1.93M-0.71M-0.43M--
Net Cash from (used by) Financing Activities
-2.07M-2.47M267.69M215.5M120.36M120.34M100.68M89.62M89.86M-
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
-75.75M-38.32M54.59M35.4M-0.42M56.87M20.73M47.43M79.56M22.5M
Cash & Equivalents at Beginning of Year136.99M82.38M61.65M146.47M18.13M12.41M13.24M1.7M7.15M-
Cash & Equivalents at Year End61.23M98.65M136.98M117.78M81.96M139.26M82.38M109.09M141.21M84.15M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Synergy Pharma stock price history and Synergy Pharma stock comparison chart inevitably reflect its cash flow situation.

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Synergy Pharma is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Synergy Pharma stock price movement.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Synergy Pharma lost $-73.49M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a negative value of $-0.19M for SGYP stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash flow from financing activities shows the flow of cash between Synergy Pharma and its owners and creditors and was $-2.07M till 2018 Q2. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Synergy Pharma Cash Flow

Quarterly Cash Flow Statements For Synergy Pharmaceuticals Inc Peers

Akebia Therapeutics cash flow, Seres Therapeutics cash flow, Progenics Pharma cash flow, PROTAGONIST THR cash flow